Showing results (91-100 of 156) with videos related to

Sort By:
Pageof 16
Annals of Nuclear Medicine|September 11, 2012
Significant impact of transient deterioration of renal function on dosimetry in PRRTSofie Van Binnebeek, Kristof Baete, Christelle Terwinghe, et al.
Nuclear Medicine and Biology|March 22, 2024
Second generation Al18F-labeled D-amino acid peptide for CXCR4 targeted molecular imagingMuriel Aline Spahn, Kaat Luyten, Tom Van Loy, et al.
International Journal of Radiation Oncology, Biology, Physics|January 31, 2012
Is there an additional value of ¹¹C-choline PET-CT to T2-weighted MRI images in the localization of intraprostatic tumor nodules?Laura Van den Bergh, Michel Koole, Sofie Isebaert, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 21, 2019
Personalised radioembolization improves outcomes in refractory intra-hepatic cholangiocarcinoma: a multicenter studyHugo Levillain, Ivan Duran Derijckere, Lieveke Ameye, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 5, 2016
Patterns of Locoregional Relapses in Patients with Contemporarily Staged Stage III-N2 NSCLC Treated with Induction Chemotherapy and Resection: Implications for Postoperative Radiotherapy Target VolumesCharlotte Billiet, Dirk De Ruysscher, Stéphanie Peeters, et al.
Acta Oncologica (Stockholm, Sweden)|February 11, 2020
Influence of pretreatment with everolimus or sunitinib on the subacute hematotoxicity of 177Lu-DOTATATE PRRTEva Medaer, Chris Verslype, Eric Van Cutsem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 13, 2012
A potent combination of the novel PI3K Inhibitor, GDC-0941, with imatinib in gastrointestinal stromal tumor xenografts: long-lasting responses after treatment withdrawalGiuseppe Floris, Agnieszka Wozniak, Raf Sciot, et al.
Pageof 16